The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Company profile

Compass Therapeutics, Inc. insider acquisitions

Company CIK 0001738021 · Reported insider acquisitions and filing context.

Company filings at SEC ↗
CMPX · Nasdaq

These are company listings. A transaction is linked to a particular security only when the filing provides enough information.

Company activity summary

By transaction date, as of October 24, 2026.

7 days30 days90 daysOverlapping periods · securities and currencies kept separate

No records are loaded for this 7-day transaction window. This does not establish that no transactions occurred.

Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Lerner NeilLerner NeilShin BarryShin BarrySirard CynthiaSirard CynthiaSchuetz Thomas J.Schuetz Thomas J.Prasad ArjunPrasad ArjunLINDAHL RICHARD SLINDAHL RICHARD SChiniara EllenChiniara EllenGRAY MARY ANNGRAY MARY ANNLerner Neil · October 1, 2026 · Purchase · Common StockShin Barry · January 2, 2026 · Stock award · Stock Option (Right to Buy)Shin Barry · January 2, 2026 · Stock award · Common StockSirard Cynthia · January 2, 2026 · Stock award · STOCK OPTION (RIGHT TO BUY)Schuetz Thomas J. · January 2, 2026 · Stock award · Stock Option (Right to Buy)Schuetz Thomas J. · January 2, 2026 · Stock award · Common StockPrasad Arjun · January 2, 2026 · Stock award · STOCK OPTION (RIGHT TO BUY)LINDAHL RICHARD S · January 2, 2026 · Stock award · Stock Option (Right to Buy)Chiniara Ellen · January 2, 2026 · Stock award · Stock Option (Right to Buy)Lerner Neil · January 2, 2026 · Stock award · Stock Option (Right to Buy)Lerner Neil · January 2, 2026 · Stock award · Common StockGRAY MARY ANN · January 2, 2026 · Stock award · Stock Option (Right to Buy)Jan 2, 2026Oct 1, 2026
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

17 dated transactions · 8 of 12 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Oct 1, 2026Compass Therapeutics, Inc.Common StockLerner NeilPurchase
Jan 2, 2026Compass Therapeutics, Inc.Stock Option (Right to Buy)Shin BarryStock award
Jan 2, 2026Compass Therapeutics, Inc.Common StockShin BarryStock award
Jan 2, 2026Compass Therapeutics, Inc.STOCK OPTION (RIGHT TO BUY)Sirard CynthiaStock award
Jan 2, 2026Compass Therapeutics, Inc.Stock Option (Right to Buy)Schuetz Thomas J.Stock award
Jan 2, 2026Compass Therapeutics, Inc.Common StockSchuetz Thomas J.Stock award
Jan 2, 2026Compass Therapeutics, Inc.STOCK OPTION (RIGHT TO BUY)Prasad ArjunStock award
Jan 2, 2026Compass Therapeutics, Inc.Stock Option (Right to Buy)LINDAHL RICHARD SStock award
Jan 2, 2026Compass Therapeutics, Inc.Stock Option (Right to Buy)Chiniara EllenStock award
Jan 2, 2026Compass Therapeutics, Inc.Stock Option (Right to Buy)Lerner NeilStock award
Jan 2, 2026Compass Therapeutics, Inc.Common StockLerner NeilStock award
Jan 2, 2026Compass Therapeutics, Inc.Stock Option (Right to Buy)GRAY MARY ANNStock award
Jan 2, 2026Compass Therapeutics, Inc.Stock Option (Right to Buy)Boylan James PStock award
Jan 2, 2026Compass Therapeutics, Inc.Stock Option (Right to Buy)GORDON CARL LStock award
Jan 2, 2026Compass Therapeutics, Inc.Stock Option (Right to Buy)Ferneau PhilipStock award
Jan 2, 2026Compass Therapeutics, Inc.Stock Option (Right to Buy)Anderman JonathanStock award
Jan 2, 2026Compass Therapeutics, Inc.Common StockAnderman JonathanStock award

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Share price & reported acquisitions

Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.

Price history is not available

Market-price history is not connected yet.

CMPX · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.

Reported acquisitions

Filing-date filters apply to the list and timeline. The summary above uses transaction dates.

Reset
Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedReporting ownersType / securityQuantityPrice / reference valueDetails
Trade:
Lerner NeilChief Accounting Officer
PurchaseCommon StockNon-derivative security · Code P20,0000.92Value: 18,400Currency not specifiedView ↗
Trade: Stock awardStock Option (Right to Buy)Derivative security · Code A670,0000Value: 0Currency not specifiedView ↗
Trade: Stock awardCommon StockNon-derivative security · Code A125,0005.17Value: 646,250Currency not specifiedView ↗
Trade:
Sirard CynthiaChief Medical Officer
Stock awardSTOCK OPTION (RIGHT TO BUY)Derivative security · Code A1,000,0000Value: 0Currency not specifiedView ↗
Trade:
Schuetz Thomas J.CEO · Director
Stock awardStock Option (Right to Buy)Derivative security · Code A2,000,0000Value: 0Currency not specifiedView ↗
Trade:
Schuetz Thomas J.CEO · Director
Stock awardCommon StockNon-derivative security · Code A250,0005.17Value: 1,292,500Currency not specifiedView ↗
Trade:
Prasad ArjunChief Commercial Officer
Stock awardSTOCK OPTION (RIGHT TO BUY)Derivative security · Code A1,000,0000Value: 0Currency not specifiedView ↗
Trade: Stock awardStock Option (Right to Buy)Derivative security · Code A90,0000Value: 0Currency not specifiedView ↗
Trade: Stock awardStock Option (Right to Buy)Derivative security · Code A90,0000Value: 0Currency not specifiedView ↗
Trade:
Lerner NeilChief Accounting Officer
Stock awardStock Option (Right to Buy)Derivative security · Code A435,0000Value: 0Currency not specifiedView ↗
Trade:
Lerner NeilChief Accounting Officer
Stock awardCommon StockNon-derivative security · Code A62,5005.17Value: 323,125Currency not specifiedView ↗
Trade: Stock awardStock Option (Right to Buy)Derivative security · Code A90,0000Value: 0Currency not specifiedView ↗
Trade: Stock awardStock Option (Right to Buy)Derivative security · Code A90,0000Value: 0Currency not specifiedView ↗
Trade: Stock awardStock Option (Right to Buy)Derivative security · Code A90,0000Value: 0Currency not specifiedView ↗
Trade: Stock awardStock Option (Right to Buy)Derivative security · Code A90,0000Value: 0Currency not specifiedView ↗
Trade:
Anderman JonathanGeneral Counsel
Stock awardStock Option (Right to Buy)Derivative security · Code A720,0000Value: 0Currency not specifiedView ↗
Trade:
Anderman JonathanGeneral Counsel
Stock awardCommon StockNon-derivative security · Code A150,0005.17Value: 775,500Currency not specifiedView ↗

Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →